Novo Nordisk shareholders approve new board chair

Core Viewpoint - Novo Nordisk's shareholders have approved Lars Rebien Sorensen as the new chairman of the company during an extraordinary shareholder meeting [1] Company Summary - The approval of Lars Rebien Sorensen as chairman indicates a significant leadership change within Novo Nordisk [1]